7 I, a structurally modified sinomenine, exerts dual anti‐GBM effects by inhibiting glioblastoma proliferation and inducing necroptosis which further mediates lysosomal cell death
This article is part of a themed issue Natural Products and Cancer: From Drug Discovery to Prevention and Therapy. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v182.10/issuetoc.
Authors
- Wanxin Cao
- Tengfei Ji (ORCID: https://orcid.org/0000-0001-6168-3325)
- Guanhua Du (ORCID: https://orcid.org/0000-0002-6896-0847)
- Yizhi Zhang (ORCID: https://orcid.org/0000-0002-0422-0006)
- Fang Xu (ORCID: https://orcid.org/0000-0002-4537-8459)
- Yihui Yang (ORCID: https://orcid.org/0000-0001-9549-4071)
- Jinhua Wang (ORCID: https://orcid.org/0000-0001-8367-0787)
- Xiaoxue Li (ORCID: https://orcid.org/0000-0002-8992-8002)
- Sen Zhang (ORCID: https://orcid.org/0000-0003-1409-5795)
- Xu Zhang (ORCID: https://orcid.org/0000-0002-2270-9286)
- Li Wan (ORCID: https://orcid.org/0000-0002-3596-3339)
- Bin Jiang (ORCID: https://orcid.org/0000-0002-4858-0505)
- Hong Yang (ORCID: https://orcid.org/0000-0002-8639-8309)
Institutions
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
Publication Details
- Journal
- British Journal of Pharmacology
- Published
- 2025-03-04
- DOI
- https://doi.org/10.1111/bph.17464
- Citations
- 6
- Primary Topic
- Berberine and alkaloids research
- Type
- article
- Field-Weighted Citation Impact
- 8.37
Funders
- National Natural Science Foundation of China